Skip to main content
    G

    Grace Therapeutics, Inc. (GRCE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.75
    -0.06 (-3.31%)

    Market Cap: $38.08M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Grace Therapeutics, Inc. (GRCE) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Grace Therapeutics are Gain Therapeutics (GANX), Plus Therapeutics (PSTV) and Quince Therapeutics (QNCX). By market cap, Grace Therapeutics ranks 5th of the 13 companies on this page; Tenax Therapeutics (TENX) is the largest at $73.77M.

    Peer Comparison

    GRCE's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Grace Therapeutics (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Spero Therapeutics Inc (SPRO)$58.26M11.1x1.3x15.7%N/A-95.6%0.00%
    Pelthos Therapeutics Inc. (PTHS)$29.24MN/A0.5x-199.5%-95.4%0.0%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Serina Therapeutics Inc (SER)$36.93MN/A288.7x0.0%-109.4%154.9%0.00%
    Tenax Therapeutics Inc (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    Transcode Therapeutics Inc (RNAZ)$22.35MN/AN/A0.0%-412.7%0.0%0.00%
    Briacell Therapeutics Corp (BCTX)$29.60MN/AN/A0.0%N/A0.0%0.00%
    Peer median$35.51M11.1x1.7x0.0%-140.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Grace Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Quince Therapeutics, Inc. (QNCX)
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.
    Spero Therapeutics Inc (SPRO)
    Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing...
    SPRO competitors
    Pelthos Therapeutics Inc. (PTHS)
    Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
    PTHS competitors
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Serina Therapeutics Inc (SER)
    Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology...
    SER competitors
    Tenax Therapeutics Inc (TENX)
    Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing...
    TENX competitors
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    Transcode Therapeutics Inc (RNAZ)
    TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic...
    RNAZ competitors
    Briacell Therapeutics Corp (BCTX)
    BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
    BCTX competitors

    Frequently Asked Questions About GRCE

    Who are Grace Therapeutics' main competitors?

    The companies most similar to Grace Therapeutics include Gain Therapeutics (GANX), Plus Therapeutics (PSTV), Quince Therapeutics (QNCX), Spero Therapeutics (SPRO) and Pelthos Therapeutics (PTHS), listed from the closest match.

    Who is Grace Therapeutics' biggest competitor?

    Tenax Therapeutics (TENX) is the largest of the similar companies at $73.77M; Gain Therapeutics (GANX) is the closest match by business profile, size, sector and industry.

    How does GRCE stock compare with its competitors?

    GRCE's net margin is 0.0% against a peer median of 0.0%.

    Which of Grace Therapeutics' competitors pays a higher dividend?

    Grace Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Grace Therapeutics bigger than its competitors?

    No. Grace Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Tenax Therapeutics (TENX) at $73.77M.